Table 1. Characteristics of patients.

The characteristics of the patients, diseases, and treatments from both study cohorts are presented. Statistical analyses were done to describe the differences between the two cohorts.

	Cohort treated from 2004-2012 with toxicity data	Cohort treated from  1998-2004 “Long-Term Cohort”	p-value
Gender (F:M)	10:15	12:11	0.44†
Age at diagnosis	Median: 56 (38-80)	59 (43-82)	0.61*
RT dose	Median: 50.4 (41.4-50.4)	45.0 (45.0-50)	0.0044*
RT technique	IMRT	21 3D-CRT (3 brachy boost), 2 IMRT
Tumor size (cm)	Median: 13.4 (5.7-28.0)	18 (5.0-41.0)	0.13*
Histology	17 liposarcoma (9 high grade)	18 liposarcoma (7 high grade)	0.67†
Tumor grade	15 High: 10 Low	10 High: 13 Low	0.11†
Primary vs. Recurrent	25 Primary	19 Primary 4 Recurrent
Number of organs resected	Median: 4.5 (1-8)	Median: 4 (0-7)	0.24*
Median follow-up	36 months	120 months